期刊文献+
共找到35,280篇文章
< 1 2 250 >
每页显示 20 50 100
GI.5和GII.4诺如病毒P蛋白的克隆表达及与长牡蛎类HBGAs的结合特性
1
作者 佟利惠 杨敏 +3 位作者 王珊珊 王大军 王明丽 周德庆 《食品科学》 EI CAS CSCD 北大核心 2024年第2期113-119,共7页
为明确人诺如病毒(human norovirus,HuNoV)与长牡蛎类组织血型抗原(histo-blood group antigens,HBGAs)的结合特性,本实验运用大肠杆菌表达系统,克隆表达了基因簇I.5(genogroup I.5,GI.5)和GII.4 HuNoV P蛋白,采用酶联免疫吸附测定研究H... 为明确人诺如病毒(human norovirus,HuNoV)与长牡蛎类组织血型抗原(histo-blood group antigens,HBGAs)的结合特性,本实验运用大肠杆菌表达系统,克隆表达了基因簇I.5(genogroup I.5,GI.5)和GII.4 HuNoV P蛋白,采用酶联免疫吸附测定研究HuNoV P蛋白与唾液HBGAs和长牡蛎类HBGAs的结合特性。结果表明,GII.4 HuNoV与唾液A型、B型、AB型和O型HBGAs均有较好的结合,而GI.5 HuNoV与B型HBGAs结合较弱,与O型HBGAs具有明显的结合优势。GI.5和GII.4 HuNoV在长牡蛎鳃、消化腺和外套膜中均可富集,其中在消化腺中富集最多,二者主要与类A型和H1型HBGAs结合,GII.4HuNoV与类Lea型、Leb型、Lex型和Ley型HBGAs有不同程度的结合,而GI.5 HuNoV与类Leb型HBGAs仅微弱结合,与类H1型HBGAs具有明显结合优势。综上,不同型别HuNoV与HBGAs的结合特性不尽相同,GII.4HuNoV具有广谱结合特性,GI.5HuNoV具有选择结合特性。 展开更多
关键词 人诺如病毒 P蛋白 长牡蛎 组织血型抗原 结合特性
下载PDF
Prevalence and Factors Associated with Positivity of Antinuclear Antibodies (ANA) Patterns, Native Anti-DNA and Extractable Nuclear Antigens (ENA) Antibodies: Experience from a Laboratory in Dakar
2
作者 Diop Abdou Diallo Thierno Abdoulaye +4 位作者 Ndiaye Babacar Mahou Chantal Diop Marième Gaye Dubrous Phillippe Seck Abdoulaye 《Open Journal of Rheumatology and Autoimmune Diseases》 2024年第1期26-36,共11页
Background: Diagnosis of autoimmune diseases (AID) is challenging, due to overlapping features with other non-immune disorders. Anti-nuclear antibodies (ANA) are sensitive screening tests but anti-deoxyribonucleic aci... Background: Diagnosis of autoimmune diseases (AID) is challenging, due to overlapping features with other non-immune disorders. Anti-nuclear antibodies (ANA) are sensitive screening tests but anti-deoxyribonucleic acid-antibody (anti-DNA), and anti-extractable nuclear antigens (anti-ENA) are specific for AIDs. We aimed to look at ANA patterns in our patients and correlated them with anti-ENA for proper interpretation and better patient management cost-effectively. Methods: A retrospective study was conducted over 1 year from January to December 2022 who were tested for ANA at biology medical laboratory of Pasteur Institute of Dakar. Anti-ENA and anti-DNA results were also analyzed for ANA-positive patients. Statistical analysis was performed using STATA 14.0, p Results: 216 patients were analyzed. Women predominated at 79.2% and mean age was 48 years [CI 95%, 46 - 50], with extremes of 10 and 89. Most represented age group was [41 - 60] with 38%. ANA was positive in 27 (12.5%) of patients, 59.2% of whom were strongly positive (titer of 1/1000, 1/3200 or 1/6400). The most common pattern was nuclear speckled, which was found in 77.8% of samples. Anti-ENA and anti-DNA positivity in ANA-positive patients was found respectively in 63% (17/27) and 1.4% (3/27) of the samples analyzed. Most commonly identified anti-ENA was anti-Sm 29.6%, anti-SSA 29.6%, anti-Ro-52 25.9%, anti-RNP 18.5% and anti-SSB 14.8% which was associated with speckled pattern. Association results indicated a significant relationship between both tests and between ANA titer in the anti-ENA- and ANA-positive patients (p 0.001). Conclusions: ANA, Anti-ENA and anti-DNA antibodies are essential for AIDS diagnosis. However, the testing repertoire should follow an algorithm comprising of clinical features, followed by ANA results with nuclear, mitotic, and cytoplasmic patterns, anti-ENA, and anti-DNA for a more meaningful, and cost-effective diagnostic approach. 展开更多
关键词 Antinuclear Antibodies Extractable Nuclear antigen Autoimmune Disease Indirect Immunofluorescence
下载PDF
Inflammatory response in gastrointestinal cancers:Overview of six transmembrane epithelial antigens of the prostate in pathophysiology and clinical implications
3
作者 Ze-Xuan Fang Wen-Jia Chen +4 位作者 Zheng Wu Yan-Yu Hou Yang-Zheng Lan Hua-Tao Wu Jing Liu 《World Journal of Clinical Oncology》 2024年第1期9-22,共14页
Chronic inflammation is known to increase the risk of gastrointestinal cancers(GICs),the common solid tumors worldwide.Precancerous lesions,such as chronic atrophic inflammation and ulcers,are related to inflammatory ... Chronic inflammation is known to increase the risk of gastrointestinal cancers(GICs),the common solid tumors worldwide.Precancerous lesions,such as chronic atrophic inflammation and ulcers,are related to inflammatory responses in vivo and likely to occur in hyperplasia and tumorigenesis.Unfortunately,due to the lack of effective therapeutic targets,the prognosis of patients with GICs is still unsatisfactory.Interestingly,it is found that six transmembrane epithelial antigens of the prostate(STEAPs),a group of metal reductases,are significantly associated with the progression of malignancies,playing a crucial role in systemic metabolic homeostasis and inflammatory responses.The structure and functions of STEAPs suggest that they are closely related to intracellular oxidative stress,responding to inflammatory reactions.Under the imbalance status of abnormal oxidative stress,STEAP members are involved in cell transformation and the development of GICs by inhibiting or activating inflammatory process.This review focuses on STEAPs in GICs along with exploring their potential molecular regulatory mechanisms,with an aim to provide a theoretical basis for diagnosis and treatment strategies for patients suffering from these types of cancers. 展开更多
关键词 Six transmembrane epithelial antigens of the prostate Gastrointestinal cancer Inflammation
下载PDF
Tumor neoantigens: Novel strategies for application of cancer immunotherapy 被引量:2
4
作者 HANYANG GUAN YUE WU +10 位作者 LU LI YABING YANG SHENGHUI QIU ZHAN ZHAO XIAODONG CHU JIASHUAI HE ZUYANG CHEN YIRAN ZHANG HUI DING JINGHUA PAN YUNLONG PAN 《Oncology Research》 SCIE 2023年第4期437-448,共12页
Neoantigen-targeted immunotherapy is a rapidly advancing field that holds great promise for treating cancer.The recognition of antigens by immune cells is a crucial step in tumor-specific killing,and neoantigens gener... Neoantigen-targeted immunotherapy is a rapidly advancing field that holds great promise for treating cancer.The recognition of antigens by immune cells is a crucial step in tumor-specific killing,and neoantigens generated by mutations in cancer cells possess high immunogenicity and are selectively expressed in tumor cells,making them an attractive therapeutic target.Currently,neoantigens find utility in various domains,primarily in the realm of neoantigen vaccines such as DC vaccines,nucleic acid vaccines,and synthetic long peptide vaccines.Additionally,they hold promise in adoptive cell therapy,encompassing tumor-infiltrating cells,T cell receptors,and chimeric antigen receptors which are expressed by genetically modified T cells.In this review,we summarized recent progress in the clinical use of tumor vaccines and adoptive cell therapy targeting neoantigens,discussed the potential of neoantigen burden as an immune checkpoint in clinical settings.With the aid of state-of-the-art sequencing and bioinformatics technologies,together with significant advancements in artificial intelligence,we anticipated that neoantigens will be fully exploited for personalized tumor immunotherapy,from screening to clinical application. 展开更多
关键词 IMMUNOTHERAPY Tumor vaccine Adoptive T cell therapy Chimeric antigen receptor
下载PDF
Expression and Evaluation of Wb-SXP-1 and Wb-123 Recombinant Antigens as Potential Diagnostic Biomarkers for Lymphatic Filariasis
5
作者 Sharlene Kerubo Mageto Rebecca Wanjiku Waihenya +11 位作者 Anne Wanjiru Mwangi Peter Kipkemboi Rotich Matthew Mutinda Munyao Tonny Teya Robinson Mugasiali Irekwa Joanne Jepkemei Yego Caroline Wangui Njoroge Grace Ng’endo Kanyita Nicole Sian Tanchu Dawala Koromtili Oumar Primrose Muthoni Ndungu Samson Muuo Nzou 《American Journal of Molecular Biology》 CAS 2023年第2期95-112,共18页
Lymphatic filariasis (LF) remains a public health concern as it can cause permanent morbidity and disability to those infected. While the global elimination of LF in these endemic areas is ongoing through mass drug ad... Lymphatic filariasis (LF) remains a public health concern as it can cause permanent morbidity and disability to those infected. While the global elimination of LF in these endemic areas is ongoing through mass drug administration, there is the need to develop diagnostic tools that would be utilized to track the progress of total global eradication as well as perform surveillance for the recurrence of lymphatic filariasis transmission. Currently, approved LF diagnosis tools are faced with lack of specificity, low sensitivity, and periodicity dependence. Recombinant filarial antigen-based assays can address these drawbacks and offer practical instruments for LF diagnosis and surveillance. This present study, evaluated rWb-SXP-1 and rWb-123 antigens as potential diagnostic biomarker tools for Wuchereria banchrofti in human sera using microspheres-based multiplex serological assay. Based on statistical analysis using XLSTAT 2019 (Addinsoft) on data generated from multiplex technology assay, generated ROC curves for both rWb-SXP-1 and rWb-123 demonstrated 87.1% sensitivity to Wuchereria banchrofti human sera with rWb-SXP-1 antigens having the highest specificity of 96%. Indication that rWb-SXP-1 and rWb-123 antigens are capable of detecting immunoglobulin G4 (IgG4) antibodies in human sera synthesized specifically against W. banchrofti infections. Therefore, rWb-SXP-1 and rWb-123 antigens can be utilized to detect W. banchrofti infections by antibody profiling with excellent diagnostic sensitivity and specificity using microsphere-based multiplex serological tests. This method can be particularly practical for screening a large number of sera samples and/or for quick, extensive field-testing due to the high-throughput and quick formats applied. 展开更多
关键词 Lymphatic Filariasis Recombinant antigens DIAGNOSIS
下载PDF
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
6
作者 Tai-Liang Lu Cheng-Long Li +2 位作者 Yong-Qiang Gong Fu-Tao Hou Chao-Wu Chen 《World Journal of Gastrointestinal Oncology》 SCIE 2023年第10期1717-1738,共22页
BACKGROUND mRNA vaccines have been investigated in multiple tumors,but limited studies have been conducted on their use for hepatocellular carcinoma(HCC).AIM To identify candidate mRNA vaccine antigens for HCC and sui... BACKGROUND mRNA vaccines have been investigated in multiple tumors,but limited studies have been conducted on their use for hepatocellular carcinoma(HCC).AIM To identify candidate mRNA vaccine antigens for HCC and suitable subpopu-lations for mRNA vaccination.METHODS Gene expression profiles and clinical information of HCC datasets were obtained from International Cancer Genome Consortium and The Cancer Genome Atlas.Genes with somatic mutations and copy number variations were identified by cBioPortal analysis.The differentially expressed genes with significant prognostic value were identified by Gene Expression Profiling Interactive Analysis 2 website analysis.The Tumor Immune Estimation Resource database was used to assess the correlation between candidate antigens and the abundance of antigen-presenting cells(APCs).Tumor-associated antigens were overexpressed in tumors and associated with prognosis,genomic alterations,and APC infiltration.A consensus cluster analysis was performed with the Consensus Cluster Plus package to identify the immune subtypes.The weighted gene coexpression network analysis(WGCNA)was used to determine the candidate biomarker molecules for appropriate populations for mRNA vaccines.immune subtypes showed distinct cellular and clinical characteristics.The IS1 and IS3 immune subtypes were immunologically“cold”.The IS2 and IS4 immune subtypes were immunologically“hot”,and the immune checkpoint genes and immunogenic cell death genes were upregulated in these subtypes.IS1-related modules were identified with the WGCNA algorithm.Ultimately,five hub genes(RBP4,KNG1,METTL7A,F12,and ABAT)were identified,and they might be potential biomarkers for mRNA vaccines.CONCLUSION AURKA,CCNB1,CDC25C,CDK1,TRIP13,PES1,MCM3,PPM1G,NEK2,KIF2C,PTTG1,KPNA2,and PRC1 have been identified as candidate HCC antigens for mRNA vaccine development.The IS1 and IS3 immune subtypes are suitable populations for mRNA vaccination.RBP4,KNG1,METTL7A,F12,and ABAT are potential biomarkers for mRNA vaccines. 展开更多
关键词 mRNA vaccine Hepatocellular carcinoma Immunotype antigens Immune subtypes
下载PDF
False positive detection of serum cryptococcal antigens due to insufficient sample dilution:A case series
7
作者 Wen-Yu Chen Cheng Zhong +1 位作者 Jian-Ying Zhou Hua Zhou 《World Journal of Clinical Cases》 SCIE 2023年第8期1837-1846,共10页
At present,with the development of technology,the detection of cryptococcal antigen(CRAG)plays an increasingly important role in the diagnosis of cryptococcosis.However,the three major CRAG detection technologies,late... At present,with the development of technology,the detection of cryptococcal antigen(CRAG)plays an increasingly important role in the diagnosis of cryptococcosis.However,the three major CRAG detection technologies,latex agglutination test(LA),lateral flow assay(LFA)and Enzyme-linked Immunosorbent Assay,have certain limitations.Although these techniques do not often lead to false-positive results,once this result occurs in a particular group of patients(such as human immunodeficiency virus patients),it might lead to severe consequences. 展开更多
关键词 CRYPTOCOCCOSIS Capsular antigen detection False positive TISSUE Case report
下载PDF
Three-dimensional models of antigens with serodiagnostic potential for leprosy:An in silico study
8
作者 Bianca Luiza Melo de Assis Rafaela Viana Vieira +4 位作者 Ian Theodoro Rudenco Gomes Palma Matheus Bertolini Coutinho Juliana de Moura Gabrielle Caroline Peiter Kádima Nayara Teixeira 《World Journal of Clinical Infectious Diseases》 2023年第1期1-10,共10页
BACKGROUND Leprosy is a disease caused by Mycobacterium leprae(M.leprae),an intracellular pathogen that has tropism and affects skin and nervous system cells.The disease has two forms of presentation:Paucibacillary an... BACKGROUND Leprosy is a disease caused by Mycobacterium leprae(M.leprae),an intracellular pathogen that has tropism and affects skin and nervous system cells.The disease has two forms of presentation:Paucibacillary and multibacillary,with different clinical and immunological manifestations.Unlike what occurs in the multibacillary form,the diagnostic tests for the paucibacillary form are nonspecific and not very sensitive,allowing the existence of infected individuals without treatment,which contributes to the spread of the pathogen in the population.To mitigate this contamination,more sensitive diagnostic tests capable of detecting paucibacillary patients are needed.AIM To predict the three-dimensional structure models of M.leprae antigens with serodiagnostic potential for leprosy.METHODS In this in silico study,satisfactory templates were selected in the Protein Data Bank(PDB)using Basic Local Alignment Search Tool to predict the structural templates of ML2038,ML0286,ML0050,and 85B antigens by comparative modeling.The templates were selected according to general criteria such as sequence identity,coverage,X-ray resolution,Global Model Quality Estimate value and phylogenetic relationship;Clustal X 2.1 software was used in this analysis.Molecular modeling was completed using the software Modeller 9v13.Visualization of the models was made using ViewerLite 4.2 and PyMol software,and analysis of the quality of the predicted models was performed using the QMEAN score and Z-score.Finally,the three-dimensional moels were validated using the MolProbity and Verify 3D platforms.RESULTS The three-dimensional structure models of ML2038,ML0286,ML0050,and 85B antigens of M.leprae were predicted using the templates PDB:3UOI(90.51%identity),PDB:3EKL(87.46%identity),PDB:3FAV(40.00%identity),and PDB:1F0N(85.21%identity),respectively.The QMEAN and Z-score values indicated the good quality of the structure models.These data refer to the monomeric units of antigens,since some of these antigens have quaternary structure.The validation of the models was performed with the final three-dimensional structure-monomer(ML0050 and 85B antigens)and quaternary structures(ML2038 and ML0286).The majority of amino acid residues were observed in favorable and allowed regions in the Ramachandran plot,indicating correct positioning of the side chain and absence of steric impediment.The MolProbity score value and Verify 3D results of all models indicated a satisfactory prediction.CONCLUSION The polarized immune response against M.leprae creates a problem in leprosy detection.The selection of immunodominant epitopes is essential for the development of more sensitive serodiagnostic tests,for this it is important to know the three-dimensional structure of the antigens,which can be predicted with bioinformatics tools. 展开更多
关键词 antigens Leprosy diagnosis Mycobacterium leprae Molecular modelling Serological test In silico study
下载PDF
Tumor-Specific Histo-Blood Group Antigens: Apropos of Two Cases
9
作者 Ferenc Baranyay 《Case Reports in Clinical Medicine》 2023年第7期232-250,共19页
Cancer cells with immunogenic properties having altered protein glycosylation, modified blood group substances have been widely studied. Due to the genetic instability occurring during carcinogenesis the glycosyltrans... Cancer cells with immunogenic properties having altered protein glycosylation, modified blood group substances have been widely studied. Due to the genetic instability occurring during carcinogenesis the glycosyltransferases may suffer from posttranslation sequence modification. The author describes 2 autopsy cases, where in the background of the unusual metastatic tumor presentation, incompatible blood group antigenic determinants have been demonstrated using blood group specific lectins and monoclonal antibodies (mAb). In the first case, reported here, a 10-year-old girl developed an acute myeloid leukemia and died in a septic endotoxin shock after successful cytostatic treatment of a juvenile signet ring cell cancer of her colon. At autopsy there were no signs of tumor except bilateral apple-sized mucinous ovarian (Krukenberg) metastases. While she had erythrocyte phenotype of blood group A, the signet ring adenocarcinoma cells expressed blood group B incompatible antigenic determinants with lectin/mAb. In the second case, the autopsy of a 78-year-old female resulted in no macroscopic tumor sign except a moderately enlarged, ham hard spleen. Light microscopy revealed adenocarcinomatous infiltration in the splenic sinusoids. The patient had blood group O, while the metastatic cells in the spleen reacted with Breast Carcinoma Antigen (BioGenex) and incompatible anti-B Banderiaeasimplicifolia agglutinin I and anti-B mAb. It proved to be a case of an occult, completely regressed breast cancer. Based on these observations the expression of tumor specific incompatible blood group antigens might occur from time to time, mostly in adenocarcinomas. Accordingly, blood group-based specific immuno-oncotherapy could be considered in some cancer cases. 展开更多
关键词 Occult Breast Cancer Krukenberg Metastasis Incompatible Tumor-Specific Histo-Blood Group antigens
下载PDF
β-受体激动剂类药物人工抗原合成方法研究进展
10
作者 孙晓亮 王晓茵 +4 位作者 方汉卿 宋翠平 赵思俊 曹旭敏 李木子 《中国动物检疫》 CAS 2024年第2期42-46,85,共6页
开展动物性食品中β-受体激动剂监测,对保障食品安全具有重要意义。免疫分析技术操作快速、灵敏度高、检测成本低,被广泛用于大批量畜禽产品的快速筛查。抗体特性是免疫检测的核心,而人工抗原合成的质量直接影响特异性抗体性能。本文主... 开展动物性食品中β-受体激动剂监测,对保障食品安全具有重要意义。免疫分析技术操作快速、灵敏度高、检测成本低,被广泛用于大批量畜禽产品的快速筛查。抗体特性是免疫检测的核心,而人工抗原合成的质量直接影响特异性抗体性能。本文主要综述了碳二亚胺法、活泼酯法、混合酸酐法、重氮化法、戊二醛法等β-受体激动剂类药物人工抗原合成方法,以及紫外光谱法、核磁共振法等人工抗原鉴定方法,以期为免疫分析等相关工作研究提供参考。 展开更多
关键词 β-受体激动剂 免疫分析 人工抗原 合成
下载PDF
为提升IPTR患者血小板输注后CCI值建立分级规避HLA抗体对应抗原方法及HLAMatchmaker的应用研究
11
作者 高素青 徐筠娉 +4 位作者 罗畅如 李大成 彭龙 刘通 邹琼彩 《中国实验血液学杂志》 CSCD 北大核心 2024年第1期242-249,共8页
目的:建立分级规避HLA抗体MFI阈值对应抗原方法,联合应用HLAMatchmaker表位计算法,选择供患者表位最小错配评分值,评估两种方法为免疫性血小板输注无效(Immune platelet transfusion refractoriness,IPTR)患者选择HLA相容性血小板供者,... 目的:建立分级规避HLA抗体MFI阈值对应抗原方法,联合应用HLAMatchmaker表位计算法,选择供患者表位最小错配评分值,评估两种方法为免疫性血小板输注无效(Immune platelet transfusion refractoriness,IPTR)患者选择HLA相容性血小板供者,在提升血小板输注后校正增加值(CCI)的应用价值。方法:采用SPRCA法完成51例IPTR患者的7807次血小板交叉配型实验,判断其免疫反应阴/阳性结果。采用Luminex单抗原流式微珠法检测患者的HLA-I类抗体,获得不同特异性抗体对应HLA-I类抗原MFI值,并将其分组及分级,强阳性组(MFI>4000,1级)、中阳性组(1000中阳性组>弱阳性组)。强阳性和中阳性组与阴性对照组之间的SPRCA实验免疫反应阳性结果检出数存在统计学差异(P<0.001),弱阳性位组和阴性对照组之间的SPRCA实验免疫反应阳性结果检出数无统计学差异(P>0.05)。设置强阳性组为相应特异性HLA位点对应抗原1级规避阈值,中阳性组为2级规避阈值,弱阳性组为3级规避阈值,在供者血小板紧缺情况下,可以不需要规避弱阳性组。规避1和2级HLA-I类抗体对应供者抗原及选择HLAMatchmaker表位错配评分数≤7血小板供者策略,24 h内CCI值均>4.5×109/L,均可获得临床血小板输注有效。结论:在为IPTR患者选择HLA-I类相容性供者时,分级规避HLA-I类抗体对应供者抗原,综合选择供受者HLAMatchmaker表位错配评分数≤7,经血小板交叉配型实验确认为阴性结果的供者选择策略,对提升IPTR患者血小板计数具有一定实际应用价值。 展开更多
关键词 血小板 人类白细胞抗原 抗体 表位 HLAMATCHMAKER
下载PDF
血清肿瘤标志物CEA、CA-199、CA125及VEGF联合检测对肺癌诊断的价值
12
作者 许蕴怡 李雪雅 +2 位作者 胡丽环 吴幸怡 刘振宁 《中国医药指南》 2024年第17期1-3,共3页
目的本研究目的在于探究肺癌患者中CEA、CA-199、CA125以及VEGF的表达情况,并评价它们在肺癌诊断和治疗中的临床应用价值。方法选取2023年1月至2023年10月期间入院接受肺部疾病检查并确诊为肺癌的84例患者作为观察组,另取80名健康人作... 目的本研究目的在于探究肺癌患者中CEA、CA-199、CA125以及VEGF的表达情况,并评价它们在肺癌诊断和治疗中的临床应用价值。方法选取2023年1月至2023年10月期间入院接受肺部疾病检查并确诊为肺癌的84例患者作为观察组,另取80名健康人作为对照组。通过t检验比较两组中的血清肿瘤标志物水平,评估其在肺癌风险评估中的应用价值。此外,采用受试者操作特征曲线(ROC)分析各指标在肺癌辅助诊断中的有效性。结果观察组与对照组比较,CEA、CA-199、CA125和VEGF的血清水平差异具有统计学意义(P<0.05)。Logistic回归分析表明,血清CEA、CA-199、CA125和VEGF水平升高与肺癌风险增加相关(P<0.05)。ROC曲线分析显示,CEA、CA-199、CA125联合VEGF在诊断肺癌方面的AUC值为0.855,明显高于单一测定。结论CEA、CA-199、CA125和VEGF的联合检测在肺癌的早期筛查、诊断和随访中具有显著的临床价值,能显著提高肺癌诊断的敏感性和特异性,可能对于肺癌患者的早期诊断和治疗决策提供较为重要参考。 展开更多
关键词 肺癌 肿瘤标志物 早期筛查 癌胚抗原 糖类抗原199 血管内皮生长因子
下载PDF
禽白血病病毒p27抗原ELISA检测试剂盒的比较与评估
13
作者 刘颖昳 胡迪 +4 位作者 刘倩倩 迟盛仁 刘琳 王传彬 顾小雪 《中国家禽》 北大核心 2024年第5期118-124,共7页
为了更好地进行禽白血病监测与净化,研究使用由蛋清、细胞培养物、胎粪等多种样品组成的样品盘对7种禽白血病病毒(Avian leukosis virus,ALV)p27抗原ELISA检测试剂盒(国产试剂盒DA、DB、DC,进口试剂盒IA、IB、IC、IDEXX)进行比较。结果... 为了更好地进行禽白血病监测与净化,研究使用由蛋清、细胞培养物、胎粪等多种样品组成的样品盘对7种禽白血病病毒(Avian leukosis virus,ALV)p27抗原ELISA检测试剂盒(国产试剂盒DA、DB、DC,进口试剂盒IA、IB、IC、IDEXX)进行比较。结果显示:从分析特性上看,试剂盒分析特异性均较好,未观察到与其他常见禽源病毒的交叉反应;与IDEXX相比,DA、IA的分析敏感性较高,DB、IC其次,DC、IB较低,对于ALV不同亚群,各种试剂盒分析敏感性差异可达2~3个稀释度;从诊断特性上看,与IDEXX相比,DB、DC和IC的诊断敏感性和诊断特异性均高于90%;DA、IA和IB与IDEXX的诊断敏感性和诊断特异性均高于80%;各试剂盒对于不同类型样品(DF-1细胞培养物、蛋清、胎粪)的诊断敏感性和诊断特异性存在差异;从重复性上看,DA和IA的批内变异系数均在15%以内。综上所述,与IDEXX相比,当前国产p27抗原ELISA检测试剂盒DA和DB、进口p27抗原ELISA检测试剂盒IA和IC的各项性能可满足禽白血病净化各阶段对不同类型样品的检测需求。 展开更多
关键词 禽白血病病毒 净化 ELISA P27抗原
下载PDF
基于二代测序的HLA-Ⅱ类等位基因多态性研究及等位基因丢失防范策略
14
作者 高素青 全湛柔 +4 位作者 钟艳平 陈浩 何柳媚 邹红岩 邓志辉 《中国实验血液学杂志》 CAS CSCD 北大核心 2024年第2期603-609,共7页
目的:研究二代测序技术(NGS)检测深圳地区随机健康无关汉族人群HLA-DRB1、DQB1、DQA1、DRB3、DRB4、DRB5、DPA1、DPB1等位基因多态性的精确性,探讨HLA-DRB1等位基因丢失的原因及室内关键质控体系建立策略。方法:采用Mi Seq DxTM NGS平台... 目的:研究二代测序技术(NGS)检测深圳地区随机健康无关汉族人群HLA-DRB1、DQB1、DQA1、DRB3、DRB4、DRB5、DPA1、DPB1等位基因多态性的精确性,探讨HLA-DRB1等位基因丢失的原因及室内关键质控体系建立策略。方法:采用Mi Seq DxTM NGS平台对1012例样本完成HLA-II类等位基因分型。对质控体系软件提示的疑难样本和HLA-DRB1纯合子样本采用PCR-SSOP法或PCR-SBT法进行确认。结果:检出HLA-DRB1、DRB3、DRB4、DRB5、DQA1、DQB1、DPA1、DPB1等位基因分别有45、7、5、7、17、21、10、27种。常见等位基因(频率>10%)有HLA-DRB1*09:01(17.09%)、15:01(10.72%);DRB3*02:02(25.99%)、03:01(10.18%);DRB4*01:03(36.46%);DRB5*01:01(15.42%);DQA1*01:02(20.01%)、03:02(17.19%);DQB1*03:01(19.47%)、03:03(17.98%)、05:02(11.66%)、06:01(10.67%);DPA1*02:02(54.45%)、01:03(31.18%);DPB1*05:01(39.13%)、02:01(16.90%)。HLA-DRB1和DQB1位点基因频率与中国常见及确认的HLA等位基因表(CWD2.4)进行统计学比较,差异无统计学意义(χ^(2)=12.68,P>0.05)。对NGS检出的94例HLA-DRB1纯合子样本采用PCR-SSOP法进行复检,检出HLA-DRB1位点漏检等位基因1例,通过SBT法确认为漏检DRB1*04:03等位基因,为此建立了本实验室室内质控体系。检出新等位基因2例,获WHO HLA系统因素命名委员会命名。结论:基于NGS-HLA分型方案的HLA分型结果,模棱两可结果比率更低。HLA-II类等位基因在深圳地区无关健康供者汉族人群中存在遗传多态性。在临床组织相容性试验中独立使用NGS方法存在局限性,需要内部质量控制策略来防范偶发的等位基因丢失事件。 展开更多
关键词 人类白细胞抗原 基因频率 二代测序 等位基因丢失
下载PDF
转录因子ATF3与前列腺癌临床相关性的分析研究
15
作者 徐凌凡 丁和康 +2 位作者 施浩强 杨诚 邰胜 《安徽医专学报》 2024年第2期90-93,共4页
目的:探究转录因子ATF3与前列腺癌的临床相关性,了解ATF3在前列腺癌组织中的表达以及其表达强度对前列腺癌患者预后的影响。方法:采用公共数据库挖掘的方法分析ATF3在前列腺癌组织中的突变情况以及ATF3在正常前列腺组织以及前列腺癌组... 目的:探究转录因子ATF3与前列腺癌的临床相关性,了解ATF3在前列腺癌组织中的表达以及其表达强度对前列腺癌患者预后的影响。方法:采用公共数据库挖掘的方法分析ATF3在前列腺癌组织中的突变情况以及ATF3在正常前列腺组织以及前列腺癌组织中的表达情况,kaplan-meier方法分析ATF3的表达强度与前列腺癌患者临床预后的相关性;免疫组化染色验证ATF3在正常前列腺组织和前列腺癌组织中的蛋白表达;患者临床信息分析ATF3的表达高低与前列腺癌临床特征的关联。结果:ATF3在前列腺癌组织中表现为高扩增突变,且ATF3在前列腺癌组织中的表达明显高于正常前列腺组织;ATF3与前列腺癌疾病的发生、进展(病灶转移)相关;高表达ATF3的前列腺癌患者预后较差。结论:ATF3的表达强度与前列腺癌的发生发展相关,可作为前列腺癌诊断及预后判断的重要指标。 展开更多
关键词 前列腺癌 ATF3 免疫组化 前列腺特异性抗原
下载PDF
良性前列腺增生患者临床参数间的相关性分析及方法学评价
16
作者 金晶 潘玥 +1 位作者 陀佳瑶 聂秀娟 《标记免疫分析与临床》 CAS 2024年第1期52-57,共6页
目的探讨良性前列腺增生患者的前列腺体积、患者年龄、血清总前列腺特异性抗原(TPSA)、血清游离前列腺特异性抗原(FPSA)、前列腺特异性抗原密度(PSAD)的相互关系,同时通过患者年龄预测前列腺体积(PV)大小的准确性。研究胶乳免疫比浊法... 目的探讨良性前列腺增生患者的前列腺体积、患者年龄、血清总前列腺特异性抗原(TPSA)、血清游离前列腺特异性抗原(FPSA)、前列腺特异性抗原密度(PSAD)的相互关系,同时通过患者年龄预测前列腺体积(PV)大小的准确性。研究胶乳免疫比浊法检测血清TPSA、FPSA水平与电化学发光法比较的可行性和实用性。方法收集172例患者的临床资料进行统计学分析,总结患者年龄、前列腺体积、TPSA、FPSA及PSAD的相关性,并使用受试者特征ROC曲线分析血清TPSA、FPSA预测前列腺体积的准确性。用两种方法同时检测血清TPSA和FPSA,比较其相关性、偏差和阴阳性符合率。结果患者TPSA,FPSA,PV随年龄增高而增大(r=0.318、0.325、0.511,P均<0.01),TPSA和FPSA也随PV增大而增高(r=0.279、0.368,P均<0.01)。与TPSA相比,FPSA与患者年龄、PV的相关性更强。TPSA水平<4ng/mL时,对于前列腺体积30~49mL、50~79mL和>80mL 3组,TPSA预测的AUC为0.621、0.708、0.913,最佳临界值分0.7、1.98、2.37ng/mL;FPSA预测的AUC为0.682、0.711、0.832,最佳临界值为0.37、0.56、0.81ng/mL。电化学发光法与胶乳免疫比浊法检测TPSA、FPSA相关性良好(r=0.986、0.975,P均<0.01);两种方法检测TPSA结果和FPSA结果的一致性良好;二者的阳性符合率、阴性符合率和总符合率分别为98.63%和90.54%、93.94%和96.94%、96.51%和94.18%,Kappa值为0.930、0.850(P均<0.01)。其精密度,线性范围和参考区间验证均符合标准。结论患者年龄、前列腺体积、TPSA水平、FPSA水平之间有显著的相关关系。血清TPSA和FPSA作为临床上独立预测PV的简便可行的因子具有较高准确性,其中FPSA预测的准确性更高。胶乳免疫比浊法与电化学发光法比较一致性较好,胶乳免疫比浊法可以作为检测TPSA和FPSA水平的推荐方法。 展开更多
关键词 良性前列腺增生 前列腺特异性抗原 游离前列腺特异性抗原 年龄 前列腺体积 胶乳免疫比浊法 电化学发光法
下载PDF
猪细小病毒病研究进展
17
作者 刘运超 陈玉梅 +3 位作者 杨苏珍 魏蔷 郝慧芳 柴书军 《动物医学进展》 北大核心 2024年第3期107-110,共4页
猪细小病毒(Porcine parvovirus,PPV)是一种无囊膜DNA病毒,主要引起母猪繁殖障碍。该病毒在全世界广泛流行,我国猪场PPV感染率高达90%以上,给养猪业带来巨大经济损失。PPV经口、鼻传播,主要侵染猪的生殖器官,引起母猪的死胎、木乃伊胎... 猪细小病毒(Porcine parvovirus,PPV)是一种无囊膜DNA病毒,主要引起母猪繁殖障碍。该病毒在全世界广泛流行,我国猪场PPV感染率高达90%以上,给养猪业带来巨大经济损失。PPV经口、鼻传播,主要侵染猪的生殖器官,引起母猪的死胎、木乃伊胎和公猪的精液质量下降。临床采用接种疫苗的方式进行防控,起到了一定的效果。论文对病毒的基因组和蛋白特征、流行病学和疫苗研究进行综述,以期为PPV的基础研究和疫苗开发提供参考。 展开更多
关键词 猪细小病毒 VLP组装 病毒抗原表位 VP2蛋白
下载PDF
PLGA纳米粒及其在生物医学领域的应用潜力
18
作者 王晓芳 符乐 +3 位作者 张盼盼 张华莹 剧勍 王亚文 《中国畜牧兽医》 CSCD 北大核心 2024年第1期33-41,共9页
聚乳酸-羟基乙酸(polylactic-co-glycolic acid, PLGA)是由单体乳酸和羟基乙酸构成的具有良好的可降解性和生物相容性的高分子聚合物,其作为新型载体和传递系统被广泛应用于生物学和医药学等领域。PLGA具有抗原展示和抗原包裹的功能,能... 聚乳酸-羟基乙酸(polylactic-co-glycolic acid, PLGA)是由单体乳酸和羟基乙酸构成的具有良好的可降解性和生物相容性的高分子聚合物,其作为新型载体和传递系统被广泛应用于生物学和医药学等领域。PLGA具有抗原展示和抗原包裹的功能,能保护包裹包括生物活性化合物(如蛋白质和多肽)、核酸及免疫调节分子在内的一系列物质,免受蛋白酶介导的黏膜表面降解,还能使药物或抗原缓慢释放,以减少免疫和用药次数,在肠道疾病治疗上有巨大的应用潜力。此外,还可将药物或抗原偶联到PLGA纳米粒表面起到抗原展示的作用,在疫苗研发和药物制备方面表现出优异特性。PLGA还可作为佐剂,增强疫苗的免疫保护效果。PLGA的表面修饰功能可用于药物的靶向递送,靶向递送治疗分子到身体的特定部位,既可减少不良副作用,同时还可提高局部原料药的浓度来提高药物疗效,是生物医学研究的一个活跃领域。PLGA纳米粒可单独或联合装载不同类型的药物,免疫原性小,且易于通过受控的化学合成进行调节,因此,PLGA作为生物医学领域应用潜力巨大的非病毒基因传递系统和药物传递平台,广泛用于疫苗制备和药物研发等领域。笔者重点综述了PLGA纳米粒的结构特征和制备方法,以及基于PLGA制备的纳米载体平台在疫苗研发和药物递送等领域的研究进展及应用前景,旨在为PLGA纳米粒的相关研究提供参考。 展开更多
关键词 聚乳酸-羟基乙酸(PLGA) 抗原展示 纳米粒 生物医学
下载PDF
泄浊解毒方改善大鼠溃疡性结肠炎和调控巨噬细胞极化机制研究
19
作者 康欣 刘建平 +4 位作者 任杰 杜明民 赵源 胡博乾 郎晓猛 《免疫学杂志》 CAS CSCD 2024年第1期65-71,共7页
目的探讨泄浊解毒方对大鼠溃疡性结肠炎的治疗作用及其对β-catenin/FOSL2/ARID5A分子及巨噬细胞极化的影响。方法建立溃疡性结肠炎大鼠模型,分为对照组、模型组、阳性组(柳氮磺胺吡啶干预)和低、中、高剂量组(泄浊解毒方干预)。干预14 ... 目的探讨泄浊解毒方对大鼠溃疡性结肠炎的治疗作用及其对β-catenin/FOSL2/ARID5A分子及巨噬细胞极化的影响。方法建立溃疡性结肠炎大鼠模型,分为对照组、模型组、阳性组(柳氮磺胺吡啶干预)和低、中、高剂量组(泄浊解毒方干预)。干预14 d后采用疾病活动指数(disease activity index,DAI)和结肠组织评分(colon mucosa damage index,CDMI)评价大鼠的状态;HE染色观察病变组织,ELISA法检测血清细胞因子TNF-α、IL-6水平,流式细胞仪检测外周血M1、M2巨噬细胞含量,RT-PCR检测iNOS、CD206及β-catenin/FOSL2/ARID5A mRNA表达,免疫组化检测结肠组织β-catenin/FOSL2/ARID5A分子的蛋白表达。结果1)低中高剂量组DAI评分、CMDI评分、血清TNF-α、IL-6水平均显著低于模型组,差异均具有统计学意义(P<0.05)。2)HE染色可见低中高剂量组结肠组织损伤与炎症浸润轻于模型组。3)低、中、高剂量组M1型巨噬细胞比例和iNOS mRNA显著低于模型组,M2型巨噬细胞比例和CD206 mRNA显著高于模型组(P<0.05)。4)低、中、高剂量组结肠组织中β-catenin和FOSL2 mRNA及蛋白表达显著高于模型组,ARID5A mRNA及蛋白表达显著低于模型组(P<0.05)。结论泄浊解毒方能有效改善大鼠溃疡性结肠炎的临床症状,下调β-catenin/FOSL2/ARID5A分子的表达,调节巨噬细胞的极化,减轻炎症反应,促进肠道恢复。 展开更多
关键词 泄浊解毒方 溃疡性结肠炎 免疫平衡 巨噬细胞 FOS样抗原2
下载PDF
钼靶和超声多普勒结合血清肿瘤标志物诊断早期乳腺癌研究
20
作者 王海霞 宋倩 +1 位作者 郑国红 曹钢 《中国医学装备》 2024年第1期82-87,共6页
目的:探讨钼靶、超声多普勒和血清肿瘤标志物中血清前列腺特异抗原(PSA)、血清糖类抗原15-3(CA153)、黏蛋白1(MUC1)、人类生长分化因子3(GDF3)单独及联合检测在早期乳腺癌诊断中的价值。方法:选取2018年1月至2021年12月在唐山市人民医... 目的:探讨钼靶、超声多普勒和血清肿瘤标志物中血清前列腺特异抗原(PSA)、血清糖类抗原15-3(CA153)、黏蛋白1(MUC1)、人类生长分化因子3(GDF3)单独及联合检测在早期乳腺癌诊断中的价值。方法:选取2018年1月至2021年12月在唐山市人民医院经病理检查确诊的96例乳腺癌患者(乳腺癌组)和同期在本院接受诊治的70例乳腺良性疾病患者(良性病灶组)以及同时选取在本院体检健康的50名体检者(健康对照组),以术后病理检查为“金标准”,比较钼靶、超声多普勒检查以及血清PSA、CA153、MUC1、GDF3单独及6者联合应用对乳腺癌的诊断价值。结果:乳腺癌组96例乳腺癌患者中有78例乳腺超声诊断为恶性,阳性检出率为81.3%;80例钼靶X射线检查诊断为恶性,阳性检出率为83.1%;乳腺癌组的血清PSA、CA153、MUC1及GDF3的水平明显高于良性病灶组和健康对照组,差异均有统计学意义(t_(良性病灶组)=8.783、10.361、11.258、18.965;t_(健康对照组)=9.564、12.658、12.688、20.163,P<0.05);以乳腺癌作为因变量,血清PSA、CA153、MUC1及GDF3为自变量,进行Logistic回归分析,血清PSA、CA153、MUC1及GDF3是乳腺癌的重要危险因素(OR=1.165、1.168、1.472、1.248,P<0.05);受试者工作特征(ROC)曲线分析各指标单独应用时:乳腺超声、钼靶,血清PSA、CA153、MUC1及GDF3的ROC曲线下面积(AUC)(95%CI)、灵敏度和特异度分别为0.723(0.595~0.851)、82.56%和67.32%,0.761(0.636~0.886)、85.79%和65.36%,0.833(0.726~0.941)、81.48%和85.73%,0.837(0.738~0.926)、61.25%和70.17%,0.768(0.648~0.889)、71.49%和80.87%,0.613(0.469~0.758)、52.94%和50.57%;而6项联合应用时AUC(95%CI)、灵敏度和特异度分别为0.958(0.905~0.999)、96.37%和84.83%,其诊断效能更高。结论:钼靶、超声多普勒和血清PSA、CA153、MUC1、GDF3联合检测效能高于单独检测,有助于早期鉴别和诊断乳腺癌。 展开更多
关键词 乳腺癌 钼靶X射线摄影 彩色多普勒超声 前列腺特异性抗原(PSA) 糖类抗原153(CA153) 黏蛋白1(MUC1) 人生长分化因子3(GDF3)
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部